These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14509675)

  • 1. Duration of effectiveness of botulinum toxin type B in the treatment of cervical dystonia.
    Lew MF
    Adv Neurol; 2004; 94():211-5. PubMed ID: 14509675
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failure.
    Dressler D; Bigalke H; Benecke R
    J Neurol; 2003 Aug; 250(8):967-9. PubMed ID: 12928917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
    Mueller J
    Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
    [No Abstract]   [Full Text] [Related]  

  • 4. Autonomic side effects of botulinum toxin type B therapy.
    Dressler D; Benecke R
    Adv Neurol; 2004; 94():315-20. PubMed ID: 14509689
    [No Abstract]   [Full Text] [Related]  

  • 5. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dystonia and headaches: clinical features and response to botulinum toxin therapy.
    Galvez-Jimenez N; Lampuri C; Patiño-Picirrillo R; Hargreave MJ; Hanson MR
    Adv Neurol; 2004; 94():321-8. PubMed ID: 14509690
    [No Abstract]   [Full Text] [Related]  

  • 8. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia.
    Jankovic J; Hunter C; Dolimbek BZ; Dolimbek GS; Adler CH; Brashear A; Comella CL; Gordon M; Riley DE; Sethi K; Singer C; Stacy M; Tarsy D; Atassi MZ
    Neurology; 2006 Dec; 67(12):2233-5. PubMed ID: 17190952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasticity of static graviceptive function in patients with cervical dystonia.
    Platho-Elwischger K; Kranz G; Sycha T; Dunkler D; Rommer P; Mueller C; Auff E; Wiest G
    J Neurol Sci; 2017 Feb; 373():230-235. PubMed ID: 28131194
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomized, double-blind study comparing the efficacy and safety of type a botulinum toxins botox and prosigne in the treatment of cervical dystonia.
    Quagliato EM; Carelli EF; Viana MA
    Clin Neuropharmacol; 2010; 33(1):22-6. PubMed ID: 19959960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type B de novo therapy of cervical dystonia: frequency of antibody induced therapy failure.
    Dressler D; Bigalke H
    J Neurol; 2005 Aug; 252(8):904-7. PubMed ID: 15761672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin therapy for cervical dystonia.
    Jankovic J
    Neurotox Res; 2006 Apr; 9(2-3):145-8. PubMed ID: 16785112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.
    Costa J; Borges A; Espírito-Santo C; Ferreira J; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004314. PubMed ID: 15674940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin in cervical dystonia.
    Tsui JK; Calne DB
    Adv Neurol; 1988; 49():473-8. PubMed ID: 3344637
    [No Abstract]   [Full Text] [Related]  

  • 17. Botulinum Toxin-Associated Prolonged Remission of Idiopathic Cervical Dystonia.
    Saranza G; Chen KS; Ganos C; Kalia LV; Chen R; Lang AE
    Can J Neurol Sci; 2021 Nov; 48(6):864-868. PubMed ID: 33397526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new botulinum toxin (Xeomin) for cervical dystonia and blepharospasm.
    Med Lett Drugs Ther; 2010 Nov; 52(1351):90-1. PubMed ID: 21068703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cervical dystonia with botulinum toxin.
    Jankovic J
    Mov Disord; 2004 Mar; 19 Suppl 8():S109-15. PubMed ID: 15027062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A.
    Brashear A; Ambrosius WT; Eckert GJ; Siemers ER
    Mov Disord; 1998 Jan; 13(1):158-61. PubMed ID: 9452343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.